(Q46896215)

26 December 2017

title

Statin use and risk of breast cancer (English)

1 reference

26 December 2017

2

Polly A Newcomb

1 reference

26 December 2017

author name string

Gaia Pocobelli

1

1 reference

26 December 2017

Amy Trentham-Dietz

3

1 reference

26 December 2017

Linda Titus-Ernstoff

4

1 reference

26 December 2017

John M Hampton

5

1 reference

26 December 2017

Kathleen M Egan

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

26 December 2017

published in

Cancer

1 reference

26 December 2017

volume

112

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

27-33

1 reference

26 December 2017

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Inhibitory effect of statins on the proliferation of human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Breast cancer growth prevention by statins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Carcinogenicity of lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Lipophilic statins merit additional study for breast cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statins and breast cancer prevention: time for randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Therapy insight: Potential of statins for cancer chemoprevention and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statins and the Risk of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statins and cancer development.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statin use and breast cancer: prospective results from the Women's Health Initiative.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statin therapy and risks for death and hospitalization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statin use and breast cancer risk in a large population-based setting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Serum lipids, lipid-lowering drugs, and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statin use and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statin use, hyperlipidaemia, and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Statin use and the risk of breast and prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

The Risk of Cancer in Users of Statins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Cancer risk among statin users: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23129

7 January 2021

Identifiers

DOI

10.1002/CNCR.23129

1 reference

26 December 2017

1 reference

26 December 2017